Compound 218
Identifiers
- Canonical SMILES:
COc1cc(CNC(=O)c2cc(ccc2Cl)-n2[nH]c3c4cnn(C)c4nc(-c4cccc(c4)C(F)(F)F)c3c2=O)ccc1O
- InChi:
InChI=1S/C30H22ClF3N6O4/c1-39-27-20(14-36-39)26-24(25(37-27)16-4-3-5-17(11-16)30(32,33)34)29(43)40(38-26)18-7-8-21(31)19(12-18)28(42)35-13-15-6-9-22(41)23(10-15)44-2/h3-12,14,38,41H,13H2,1-2H3,(H,35,42)
- InChiKey:
IJFMOURLOBWRKH-UHFFFAOYSA-N
External links
168318273 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD80 / CD28 | 7.26 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 622.13 g/mol | |||
HBA | 10 | |||
HBD | 3 | |||
HBA + HBD | 13 | |||
AlogP | 5.93 | |||
TPSA | 121.61 | |||
RB | 7 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4702 | N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide | DB08349 | |
0.4588 | Merestinib | DB12381 | |
0.4514 | ATX-914 | DB12673 | |
0.4462 | 1-ethyl-N-(phenylmethyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide | DB06909 | |
0.4425 | Risdiplam | DB15305 | |
0.4380 | Riociguat | DB08931 | |
0.4375 | CE-224535 | DB12113 | |
0.4340 | Tepotinib | DB15133 | |
0.4302 | Decoglurant | DB11923 | |
0.4280 | Garenoxacin | DB06160 | |
0.4264 | Ispinesib | DB06188 | |
0.4255 | Vericiguat | DB15456 | |
0.4222 | TAS-116 | DB14876 | |
0.4212 | 6-(3,4-DIHYDROXYBENZYL)-3-ETHYL-1-(2,4,6-TRICHLOROPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4(5H)-ONE | DB07606 | |
0.4210 | MK-0249 | DB11910 |